FDA NDC Directory · JSON-LD · Markdown

Enhertu

NDC 65597-406 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namefam-trastuzumab deruxtecan-nxki
Labeler / ManufacturerDaiichi Sankyo Inc.
Marketing categoryBiologic License Application · App BLA761139
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRASTUZUMAB DERUXTECAN (100 mg/5mL)
Marketing started20191220
Package count1

External sources

Source: openFDA. Public-domain (CC0).